Fund Holdings — Frazier Life Sciences Management, L.P.

Total Portfolio Value:
$4.59B
Total Bought:
$440.43M
Total Sold:
$415.62M
Net Transaction:
+$24.82M
Notable People:
James Newman Topper, Patrick James Heron, Daniel Estes, James Brush, Albert (Nmn) Cha, Frazier Life Sciences Management,
Securities
▲▼
SharesValue
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Mirum Pharmaceuticals, Inc.(MIRM)7,679,6847,679,6840$709.45M$899.06M19.58%+$189.61M
NEWAMSTERDAM PHARMA COMPANY
ORDINARY SHARES
16,943,77418,088,902+1,145,128$542.37M$613.03M13.35%+$70.66M
Erasca, Inc.(ERAS)24,675,18824,975,188+300,000$399.24M$457.55M9.96%+$58.30M
MBX Biosciences, Inc.(MBX)6,652,0136,652,0130$198.56M$367.19M8.00%+$168.63M
Arcutis Biotherapeutics, Inc.(ARQT)9,874,5119,874,5110$232.64M$258.91M5.64%+$26.27M
Trevi Therapeutics, Inc.(TRVI)9,939,5479,939,447-100$118.58M$185.37M4.04%+$66.79M
Krystal Biotech, Inc.(KRYS)481,307481,3070$124.33M$178.89M3.90%+$54.56M
Maze Therapeutics, Inc.(MAZE)4,567,2745,032,915+465,641$136.33M$150.18M3.27%+$13.85M
PHATHOM PHARMACEUTICALS INC12,466,48912,466,4890$138.50M$135.26M2.95%-$3.24M
Palvella Therapeutics, Inc.(PVLA)882,400882,4000$109.99M$134.85M2.94%+$24.86M
BridgeBio Pharma, Inc.(BBIO)3,448,1391,548,139-1,900,000$256.06M$115.31M2.51%-$140.75M
Disc Medicine, Inc.(IRON)1,354,8521,354,8520$86.63M$99.09M2.16%+$12.46M
Cytokinetics, Incorporated(CYTK)1,159,8791,159,8790$76.45M$98.81M2.15%+$22.36M
Dyne Therapeutics, Inc.(DYN)3,153,0823,153,0820$57.17M$70.03M1.53%+$12.86M
Ascendis Pharma A/S(ASND)133,333225,155+91,822$30.50M$60.05M1.31%+$29.56M
Savara Inc.(SVRA)9,720,8529,720,8520$53.08M$59.88M1.30%+$6.80M
PARABILIS MEDICINES INC01,920,805+1,920,805$0$52.57M1.14%+$52.57M
AURA BIOSCIENCES INC5,100,0007,100,000+2,000,000$34.12M$50.41M1.10%+$16.29M
ACHIEVE LIFE SCIENCE INC07,614,836+7,614,836$0$49.72M1.08%+$49.72M
Vor Biopharma Inc.(VOR)2,543,9392,543,9390$45.38M$46.83M1.02%+$1.45M
ALLOGENE THERAPEUTICS INC3,796,66822,446,668+18,650,000$9.26M$46.69M1.02%+$37.43M
Tarsus Pharmaceuticals, Inc.(TARS)728,644728,6440$51.11M$45.86M1.00%-$5.25M
BioCryst Pharmaceuticals, Inc.(BCRX)4,009,2404,009,2400$38.17M$40.09M0.87%+$1.92M
Alkermes plc(ALKS)700,647700,6470$24.77M$36.71M0.80%+$11.94M
ACADIA PHARMACEUTICALS INC1,438,1981,438,1980$32.01M$36.39M0.79%+$4.37M
Zai Lab Limited(ZLAB)1,902,3201,902,3200$35.78M$36.14M0.79%+$361.4K
MannKind Corporation(MNKD)5,900,0006,600,000+700,000$14.46M$28.12M0.61%+$13.66M
DESIGN THERAPEUTICS INC01,809,854+1,809,854$0$26.19M0.57%+$26.19M
ACLARIS THERAPEUTICS INC4,925,3744,925,3740$18.47M$26.06M0.57%+$7.59M
SHATTUCK LABS INC03,750,000+3,750,000$0$26.02M0.57%+$26.02M
KAILERA THERAPEUTICS INC01,100,000+1,100,000$0$24.23M0.53%+$24.23M
Monte Rosa Therapeutics, Inc.(GLUE)1,000,0001,000,0000$16.45M$24.20M0.53%+$7.75M
LEXEO THERAPEUTICS INC4,424,7254,824,725+400,000$25.40M$22.46M0.49%-$2.94M
Relay Therapeutics, Inc.(RLAY)01,015,693+1,015,693$0$19.00M0.41%+$19.00M
EVOLUS INC2,630,6652,630,6650$10.81M$18.26M0.40%+$7.44M
Immunocore Holdings plc(IMCR)484,782484,7820$14.62M$15.39M0.34%+$775.7K
VALNEVA SE2,291,6662,291,6660$14.32M$11.99M0.26%-$2.34M
NEWAMSTERDAM PHARMA COMPANY
*W EXP 99/99/999
500,333500,3330$10.03M$10.69M0.23%+$665.4K
AUTOLUS THERAPEUTICS LTD4,447,9104,447,9100$6.14M$7.12M0.15%+$978.5K
XILIO THERAPEUTICS INC422,505422,5050$3.55M$4.05M0.09%+$494.3K
IBIO INC1,953,4671,953,4670$3.71M$3.42M0.07%-$293.0K
Agios Pharmaceuticals, Inc.(AGIO)1,256,0800-1,256,080$42.49M$0—-$42.49M
KALVISTA PHARMACEUTICALS INC4,961,1080-4,961,108$99.87M$0—-$99.87M
Revolution Medicines, Inc.(RVMD)675,6860-675,686$65.71M$0—-$65.71M
Page 1 of 1
Frazier Life Sciences Management, L.P. — 13F Holdings — Q2 2026 | TickerTrail